Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ajt.15935 http://scihub22266oqcxt.onion/10.1111/ajt.15935 32324331!7264495!32324331     free     free     free  :  Publisher Nephropedia Template TP {{tp|p=32324331|t=2020. COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine |pdf=|usr=}} gab.com Text COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine JO: Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=32324331 #FOAvip Coronavirus disease 2019 (COVID-19) pneumonia has been poorly reported in solid organ transplanted patients; prognosis is uncertain and best management unclear. We describe the case of a 61-year-old kidney transplant recipient with several comorbidities who was hospitalized and later received a diagnosis of COVID-19 pneumonia; the infection was successfully managed with the use of hydroxychloroquine and a single administration of tocilizumab, after immunosuppression reduction; the patient did not require mechanical ventilation. During the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, transplant clinicians should be readily informed about new cases of COVID-19 pneumonia in solid organ transplant recipients, with focus on therapeutic strategies employed and their outcome. Twit Text FOAVip COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine 🦆🦆Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=32324331 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32324331 #FOAvip English Wikipedia <ref>{{Cite pmid|32324331}}</ref> COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine #MMPMID32324331 Fontana F; Alfano G; Mori G; Amurri A; Tei L; Ballestri M; Leonelli M; Facchini F; Damiano F; Magistroni R; Cappelli G Am J Transplant 2020[Jul]; 20 (7): 1902-1906 PMID32324331show ga Coronavirus disease 2019 (COVID-19) pneumonia has been poorly reported in solid organ transplanted patients; prognosis is uncertain and best management unclear. We describe the case of a 61-year-old kidney transplant recipient with several comorbidities who was hospitalized and later received a diagnosis of COVID-19 pneumonia; the infection was successfully managed with the use of hydroxychloroquine and a single administration of tocilizumab, after immunosuppression reduction; the patient did not require mechanical ventilation. During the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, transplant clinicians should be readily informed about new cases of COVID-19 pneumonia in solid organ transplant recipients, with focus on therapeutic strategies employed and their outcome. |*Kidney Transplantation[MESH] |Antibodies, Monoclonal, Humanized/*administration & dosage[MESH] |Antiviral Agents/administration & dosage[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Comorbidity[MESH] |Coronavirus Infections/complications/drug therapy/*therapy[MESH] |Humans[MESH] |Hydroxychloroquine/*administration & dosage[MESH] |Immunosuppressive Agents/*administration & dosage[MESH] |Kidney Failure, Chronic/*complications/surgery[MESH] |Male[MESH] |Middle Aged[MESH] |Nephritis, Interstitial/*complications/surgery[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/*therapy[MESH] |Respiration, Artificial[MESH] |Risk Assessment[MESH] |SARS-CoV-2[MESH] |Treatment Outcome[MESH]COVID-19 pneumonia in a kidney transplant recipient successfully treat(epmc).pdf DeepDyve Pubget Overpricing